Class information for:
Level 1: EPOETIN ALFA//CHEMOTHERAPY INDUCED ANEMIA//DARBEPOETIN ALFA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5357 1635 37.5 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
332 3       ERYTHROPOIETIN//ANEMIA//FERRITIN 37752
388 2             ERYTHROPOIETIN//ANEMIA//IRON DEFICIENCY 16969
5357 1                   EPOETIN ALFA//CHEMOTHERAPY INDUCED ANEMIA//DARBEPOETIN ALFA 1635

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EPOETIN ALFA authKW 827675 6% 43% 104
2 CHEMOTHERAPY INDUCED ANEMIA authKW 716113 3% 91% 42
3 DARBEPOETIN ALFA authKW 556805 5% 35% 86
4 ERYTHROPOIETIN authKW 533583 24% 7% 390
5 ANEMIA authKW 516024 27% 6% 440
6 ERYTHROPOIESIS STIMULATING AGENTS authKW 421290 5% 25% 89
7 ERYTHROPOIETIN RECEPTOR authKW 401901 5% 26% 83
8 EPOETIN BETA authKW 333907 3% 44% 41
9 CHEMOTHERAPY INDUCED ANAEMIA authKW 321017 1% 90% 19
10 ANAEMIA authKW 209844 10% 7% 163

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 23542 61% 0% 1004
2 Hematology 4353 16% 0% 266
3 Health Care Sciences & Services 779 5% 0% 83
4 Rehabilitation 244 3% 0% 48
5 Medicine, General & Internal 225 7% 0% 116
6 Medicine, Research & Experimental 221 6% 0% 90
7 Radiology, Nuclear Medicine & Medical Imaging 214 6% 0% 93
8 Pharmacology & Pharmacy 97 7% 0% 118
9 Transplantation 53 2% 0% 26
10 Obstetrics & Gynecology 50 3% 0% 41

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 P ONCOL UNIT PULMONOL 98906 1% 38% 14
2 MULTIDISCIPLINAIRE ONCOL 86731 1% 39% 12
3 AFDELING ONCOL HEMATOL 74697 0% 100% 4
4 JOAN KARNELL CANC 53784 1% 26% 11
5 GEN THORAC THYROID SURG 37349 0% 100% 2
6 ORTHO BIOTECH 29874 0% 40% 4
7 GERIATR NURSING CLIN 28009 0% 50% 3
8 MOL CELLULAR IMMUNOMORPHOL BASES ONCOHEMATO 28009 0% 50% 3
9 BREAST CARE SIDNEY KIMMEL CANC 24898 0% 67% 2
10 MED ABT ONKOL HAEMATOL 1 24898 0% 67% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOLOGIST 22778 3% 2% 52
2 SUPPORTIVE CARE IN CANCER 7643 3% 1% 42
3 SEMINARS IN ONCOLOGY 6886 3% 1% 44
4 SEMINARS IN HEMATOLOGY 4302 1% 1% 21
5 ONCOLOGY-NEW YORK 4089 1% 1% 18
6 CURRENT MEDICAL RESEARCH AND OPINION 3727 2% 1% 30
7 STRAHLENTHERAPIE UND ONKOLOGIE 3312 1% 1% 21
8 ANNALS OF ONCOLOGY 2889 2% 0% 36
9 MEDICAL ONCOLOGY 2719 1% 1% 22
10 CLINICAL & TRANSLATIONAL ONCOLOGY 2670 1% 1% 14

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 EPOETIN ALFA 827675 6% 43% 104 Search EPOETIN+ALFA Search EPOETIN+ALFA
2 CHEMOTHERAPY INDUCED ANEMIA 716113 3% 91% 42 Search CHEMOTHERAPY+INDUCED+ANEMIA Search CHEMOTHERAPY+INDUCED+ANEMIA
3 DARBEPOETIN ALFA 556805 5% 35% 86 Search DARBEPOETIN+ALFA Search DARBEPOETIN+ALFA
4 ERYTHROPOIETIN 533583 24% 7% 390 Search ERYTHROPOIETIN Search ERYTHROPOIETIN
5 ANEMIA 516024 27% 6% 440 Search ANEMIA Search ANEMIA
6 ERYTHROPOIESIS STIMULATING AGENTS 421290 5% 25% 89 Search ERYTHROPOIESIS+STIMULATING+AGENTS Search ERYTHROPOIESIS+STIMULATING+AGENTS
7 ERYTHROPOIETIN RECEPTOR 401901 5% 26% 83 Search ERYTHROPOIETIN+RECEPTOR Search ERYTHROPOIETIN+RECEPTOR
8 EPOETIN BETA 333907 3% 44% 41 Search EPOETIN+BETA Search EPOETIN+BETA
9 CHEMOTHERAPY INDUCED ANAEMIA 321017 1% 90% 19 Search CHEMOTHERAPY+INDUCED+ANAEMIA Search CHEMOTHERAPY+INDUCED+ANAEMIA
10 ANAEMIA 209844 10% 7% 163 Search ANAEMIA Search ANAEMIA

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 TONIA, T , METTLER, A , ROBERT, N , SCHWARZER, G , SEIDENFELD, J , WEINGART, O , HYDE, C , ENGERT, A , BOHLIUS, J , (2012) ERYTHROPOIETIN OR DARBEPOETIN FOR PATIENTS WITH CANCER.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - 218 75% 8
2 WILSON, J , YAO, GL , RAFTERY, J , BOHLIUS, J , BRUNSKILL, S , SANDERCOCK, J , BAYLISS, S , MOSS, P , STANWORTH, S , HYDE, C , (2007) A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION OF EPOETIN ALFA, EPOETIN BETA AND DARBEPOETIN ALFA IN ANAEMIA ASSOCIATED WITH CANCER, ESPECIALLY THAT ATTRIBUTABLE TO CANCER TREATMENT.HEALTH TECHNOLOGY ASSESSMENT. VOL. 11. ISSUE 13. P. 1-+ 180 75% 88
3 CRATHORNE, L , HUXLEY, N , HAASOVA, M , SNOWSILL, T , JONES-HUGHES, T , HOYLE, M , BRISCOE, S , COELHO, H , LONG, L , MEDINA-LARA, A , ET AL (2016) THE EFFECTIVENESS AND COST-EFFECTIVENESS OF ERYTHROPOIESIS-STIMULATING AGENTS (EPOETIN AND DARBEPOETIN) FOR TREATING CANCER TREATMENT-INDUCED ANAEMIA (INCLUDING REVIEW OF TECHNOLOGY APPRAISAL NO. 142): A SYSTEMATIC REVIEW AND ECONOMIC MODEL.HEALTH TECHNOLOGY ASSESSMENT. VOL. 20. ISSUE 13. P. 1 -+ 144 79% 1
4 BOHLIUS, J , SCHMIDLIN, K , BRILLANT, C , SCHWARZER, G , TRELLE, S , SEIDENFELD, J , ZWAHLEN, M , CLARKE, MJ , WEINGART, O , KLUGE, S , ET AL (2009) ERYTHROPOIETIN OR DARBEPOETIN FOR PATIENTS WITH CANCER - META-ANALYSIS BASED ON INDIVIDUAL PATIENT DATA.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - 142 73% 41
5 BOHLIUS, J , WILSON, J , SEIDENFELD, J , PIPER, M , SCHWARZER, G , SANDERCOCK, J , TRELLE, S , WEINGART, O , BAYLISS, S , BRUNSKILL, S , ET AL (2006) ERYTHROPOIETIN OR DARBEPOETIN FOR PATIENTS WITH CANCER.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - 114 69% 58
6 DEBELJAK, N , SOLAR, P , SYTKOWSKI, AJ , (2014) ERYTHROPOIETIN AND CANCER: THE UNINTENDED CONSEQUENCES OF ANEMIA CORRECTION.FRONTIERS IN IMMUNOLOGY. VOL. 5. ISSUE . P. - 102 60% 15
7 GLASPY, J , CRAWFORD, J , VANSTEENKISTE, J , HENRY, D , RAO, S , BOWERS, P , BERLIN, JA , TOMITA, D , BRIDGES, K , LUDWIG, H , (2010) ERYTHROPOIESIS-STIMULATING AGENTS IN ONCOLOGY: A STUDY-LEVEL META-ANALYSIS OF SURVIVAL AND OTHER SAFETY OUTCOMES.BRITISH JOURNAL OF CANCER. VOL. 102. ISSUE 2. P. 301 -315 68 85% 109
8 BENNETT, CL , LAI, SY , HENKE, M , BARNATO, SE , ARMITAGE, JO , SARTOR, O , (2010) ASSOCIATION BETWEEN PHARMACEUTICAL SUPPORT AND BASIC SCIENCE RESEARCH ON ERYTHROPOIESIS-STIMULATING AGENTS.ARCHIVES OF INTERNAL MEDICINE. VOL. 170. ISSUE 16. P. 1490 -1498 73 87% 11
9 BENNETT, CL , SILVER, SM , DJULBEGOVIC, B , SAMARAS, AT , BLAU, CA , GLEASON, KJ , BARNATO, SE , ELVERMAN, KM , COURTNEY, DM , MCKOY, JM , ET AL (2008) VENOUS THROMBOEMBOLISM AND MORTALITY ASSOCIATED WITH RECOMBINANT ERYTHROPOIETIN AND DARBEPOETIN ADMINISTRATION FOR THE TREATMENT OF CANCER-ASSOCIATED ANEMIA.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 299. ISSUE 8. P. 914-924 43 91% 385
10 VANSTEENKISTE, J , WAUTERS, I , ELLIOTT, S , GLASPY, J , HEDENUS, M , (2013) CHEMOTHERAPY-INDUCED ANEMIA: THE STORY OF DARBEPOETIN ALFA.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 29. ISSUE 4. P. 325-337 65 88% 2

Classes with closest relation at Level 1


Rank Class id link
1 3692 ERYTHROPOIETIN//CELLULAR MOL CEREBRAL I EMIA//CARBAMYLATED ERYTHROPOIETIN
2 5041 ERYTHROPOIETIN//BLOOD DOPING//ANTIANEMIC AGENTS
3 10920 SOLUBLE TRANSFERRIN RECEPTOR//SERUM TRANSFERRIN RECEPTOR//ANEMIA OF CHRONIC DISEASE
4 1303 ERYTHROPOIETIN//ANEMIA//ERYTHROPOIESIS STIMULATING AGENTS
5 7880 ERYTHROPOIETIN RECEPTOR//ERYTHROPOIESIS//ERYTHROBLASTIC ISLAND
6 2109 CARBOGEN//TUMOR HYPOXIA//TUMOR OXYGENATION
7 9077 INTRAVENOUS IRON//IRON SUCROSE//IRON DEXTRAN
8 3206 CANCER RELATED FATIGUE//SYMPTOM CLUSTERS//FATIGUE
9 14993 BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES//CT P13
10 6563 LEUKOREDUCTION//BLOOD TRANSFUSION//LEUCODEPLETION

Go to start page